Gastrointestinal Biosciences Clinical Trials, LLC /ID# 200931

Los Angeles, California 90067-2001

0 studies enrolling now · 1 studies all time

What they study most

Ulcerative Colitis (UC)

Studies at this site

• A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed